Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:E9Q's ROA % is ranked better than 59.53% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 1.8
vs FRA:E9Q: 3.68
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Guangdong Kanghua Healthcare Group Co ROA % Related Terms
Guangdong Kanghua Healthcare Group Co ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's ROA % distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a ROA % of 4.25% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. This is 14% above median its historical median of 3.73. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #276 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 40.5%.
Is Guangdong Kanghua Healthcare Group Co's ROA % too high?
Guangdong Kanghua Healthcare Group Co's current ROA % of 4.25% is 14% above median its 10-year median of 3.73. The Healthcare Providers & Services industry median ROA % is 1.80. Guangdong Kanghua Healthcare Group Co's value of 4.25% is 136.1% above this industry median. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #276 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #276 out of 682 companies for ROA %. This puts Guangdong Kanghua Healthcare Group Co in the upper half of its industry. The industry median ROA % is 1.80. Guangdong Kanghua Healthcare Group Co's value of 4.25% is 136.1% above this benchmark. While the company's 10-year median is 3.73 vs. the industry median of 1.80, Guangdong Kanghua Healthcare Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.80, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Kanghua Healthcare Group Co's current ROA % of 4.25% is 136.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current ROA % is 4.25%, which is 14% above median its own 10-year median of 3.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current ROA % of 4.25%. The stock's GF Value™ is €0.20, compared to a current price of €0.17 — trading 13.5% below its estimated fair value. The current ROA % is 4.25%, which is 14% above median its 10-year median of 3.73 and 136.1% above the Healthcare Providers & Services industry median of 1.80. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current ROA % is 4.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.17 is trading 13.5% below its estimated GF Value™ of €0.20.
Key valuation signals for FRA:E9Q:
ROA %: 4.25% (14% above median its 10-year median of 3.73)
GF Value™: €0.20 vs. price of €0.17 (13.5% below fair value)
Industry Position: 136.1% above the Healthcare Providers & Services median (#276 of 682)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Business Description
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
84GF Score
Get the complete analysis for FRA:E9Q
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
